MDT240816C85000
- 0.01
- -0.02-66.67%
Medtronic Newsroom
The Trader: Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barron's
Medtronic To Go Ex-Dividend On September 27th, 2024 With 0.7 USD Dividend Per Share
Catalyst Watch: Eyes on Jackson Hole, Target Earnings, and Canadian Rails Disruption
Unusual Options Activity: CRWD, GEV and Others Attract Market Bets, CRWD V/OI Ratio Reaches 70.8
Express News | Medtronic PLC - Approved Company's Cash Dividend for Q2 of Fiscal Year 2025 of $0.70 per Ordinary Share
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
Press Releases
Medtronic Announces Partnership With Abbott to Improve Faltering Diabetes Care Segment
Express News | Medtronic PLC : UBS Raises to Neutral From Sell
Express News | Medtronic PLC : UBS Raises Target Price to $90 From $76
Medtronic Upgraded at UBS on Diabetes Turnaround
Medtronic (MDT) Progresses in CGM With New Approval, Alliance
Seeking Clues to Medtronic (MDT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Medtronic Raised to Neutral From Sell by UBS
Medtronic Plc (NYSE:MDT) Is a Favorite Amongst Institutional Investors Who Own 87%
UBS Upgrades Medtronic(MDT.US) to Hold Rating, Raises Target Price to $90
Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Medtronic (MDT) and Cardinal Health (CAH)
Analysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Medtronic (MDT)
Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barrons.com